Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 3
1968 7
1969 10
1970 1
1971 5
1972 2
1974 5
1975 4
1976 1
1977 4
1978 5
1979 4
1980 4
1981 7
1982 9
1983 5
1984 5
1985 5
1986 3
1987 7
1988 5
1989 3
1990 5
1991 3
1992 3
1993 1
1994 2
1995 5
1996 1
1997 1
1998 1
1999 6
2001 3
2002 4
2003 3
2004 2
2005 2
2006 1
2007 3
2008 2
2009 3
2010 1
2011 4
2012 3
2013 3
2014 3
2015 5
2016 1
2017 3
2018 9
2019 5
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

190 results
Results by year
Filters applied: . Clear all
Page 1
Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial.
Huttner A, Kowalczyk A, Turjeman A, Babich T, Brossier C, Eliakim-Raz N, Kosiek K, Martinez de Tejada B, Roux X, Shiber S, Theuretzbacher U, von Dach E, Yahav D, Leibovici L, Godycki-Cwirko M, Mouton JW, Harbarth S. Huttner A, et al. JAMA. 2018 May 1;319(17):1781-1789. doi: 10.1001/jama.2018.3627. JAMA. 2018. PMID: 29710295 Free PMC article. Clinical Trial.
IMPORTANCE: The use of nitrofurantoin and fosfomycin has increased since guidelines began recommending them as first-line therapy for lower urinary tract infection (UTI). ...INTERVENTIONS: Participants were randomized in a 1:1 ratio to oral nitrofurantoin, 100 mg 3 …
IMPORTANCE: The use of nitrofurantoin and fosfomycin has increased since guidelines began recommending them as first-line therapy for …
D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial.
Kranjčec B, Papeš D, Altarac S. Kranjčec B, et al. World J Urol. 2014 Feb;32(1):79-84. doi: 10.1007/s00345-013-1091-6. Epub 2013 Apr 30. World J Urol. 2014. PMID: 23633128 Clinical Trial.

Patients in D-mannose group and Nitrofurantoin group had a significantly lower risk of recurrent UTI episode during prophylactic therapy compared to patients in no prophylaxis group (RR 0.239 and 0.335, P < 0.0001). ...Patients in D-mannose group had a significantly low

Patients in D-mannose group and Nitrofurantoin group had a significantly lower risk of recurrent UTI episode during prophylactic ther …
Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial.
Kazemier BM, Koningstein FN, Schneeberger C, Ott A, Bossuyt PM, de Miranda E, Vogelvang TE, Verhoeven CJ, Langenveld J, Woiski M, Oudijk MA, van der Ven JE, Vlegels MT, Kuiper PN, Feiertag N, Pajkrt E, de Groot CJ, Mol BW, Geerlings SE. Kazemier BM, et al. Lancet Infect Dis. 2015 Nov;15(11):1324-33. doi: 10.1016/S1473-3099(15)00070-5. Epub 2015 Aug 5. Lancet Infect Dis. 2015. PMID: 26255208 Clinical Trial.
Asymptomatic bacteriuria-positive women were eligible to participate in the randomised controlled trial comparing nitrofurantoin with placebo treatment. In this trial, participants were randomly assigned 1:1 to receive either nitrofurantoin 100 mg or identical place …
Asymptomatic bacteriuria-positive women were eligible to participate in the randomised controlled trial comparing nitrofurantoin with …
Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial.
Fisher H, Oluboyede Y, Chadwick T, Abdel-Fattah M, Brennand C, Fader M, Harrison S, Hilton P, Larcombe J, Little P, McClurg D, McColl E, N'Dow J, Ternent L, Thiruchelvam N, Timoney A, Vale L, Walton K, von Wilamowitz-Moellendorff A, Wilkinson J, Wood R, Pickard R. Fisher H, et al. Lancet Infect Dis. 2018 Sep;18(9):957-968. doi: 10.1016/S1473-3099(18)30279-2. Epub 2018 Jun 28. Lancet Infect Dis. 2018. PMID: 30037647 Free PMC article. Clinical Trial.
However, resistance against the antibiotics used for UTI treatment was more frequent in urinary isolates from the prophylaxis group than in those from the control group at 9-12 months of trial participation (nitrofurantoin 12 [24%] of 51 participants from the prophylaxis g …
However, resistance against the antibiotics used for UTI treatment was more frequent in urinary isolates from the prophylaxis group than in …
Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCT.
Pickard R, Chadwick T, Oluboyede Y, Brennand C, von Wilamowitz-Moellendorff A, McClurg D, Wilkinson J, Ternent L, Fisher H, Walton K, McColl E, Vale L, Wood R, Abdel-Fattah M, Hilton P, Fader M, Harrison S, Larcombe J, Little P, Timoney A, N'Dow J, Armstrong H, Morris N, Walker K, Thiruchelvam N. Pickard R, et al. Health Technol Assess. 2018 May;22(24):1-102. doi: 10.3310/hta22240. Health Technol Assess. 2018. PMID: 29766842 Free PMC article. Clinical Trial.
INTERVENTIONS: A central randomisation system using random block allocation set by an independent statistician allocated participants to the experimental group [once-daily oral antibiotic prophylaxis using either 50 mg of nitrofurantoin, 100 mg of trimethoprim (Kent Pharma …
INTERVENTIONS: A central randomisation system using random block allocation set by an independent statistician allocated participants to the …
Retrospective evaluation of nitrofurantoin and pivmecillinam for the treatment of lower urinary tract infections in men.
Montelin H, Forsman KJ, Tängdén T. Montelin H, et al. PLoS One. 2019 Jan 25;14(1):e0211098. doi: 10.1371/journal.pone.0211098. eCollection 2019. PLoS One. 2019. PMID: 30682092 Free PMC article. Clinical Trial.
OBJECTIVES: This study aimed to retrospectively assess the clinical outcome with nitrofurantoin and pivmecillinam for lower urinary tract infections (UTI) in men. ...Treatment failure occurred in one patient treated with nitrofurantoin and in four patients treated w …
OBJECTIVES: This study aimed to retrospectively assess the clinical outcome with nitrofurantoin and pivmecillinam for lower urinary t …
A randomized clinical trial comparing Nitrofurazone-coated and uncoated urinary catheters in kidney transplant recipients: Results from a pilot study.
Menezes FG, Corrêa L, Medina-Pestana JO, Aguiar WF, Camargo LFA. Menezes FG, et al. Transpl Infect Dis. 2019 Apr;21(2):e13031. doi: 10.1111/tid.13031. Epub 2018 Dec 5. Transpl Infect Dis. 2019. PMID: 30451342 Clinical Trial.
Patients with asymptomatic bacteriuria or urinary tract infection at baseline, deceased kidney transplant donors, patients with known hypersensitivity to nitrofurantoin, pregnancy, and those refusing to sign the informed consent form were excluded from the study. ...
Patients with asymptomatic bacteriuria or urinary tract infection at baseline, deceased kidney transplant donors, patients with known hypers …
The pharmacokinetics of nitrofurantoin in healthy female volunteers: a randomized crossover study.
Huttner A, Wijma RA, Stewardson AJ, Olearo F, Von Dach E, Harbarth S, Brüggemann RJM, Mouton JW, Muller AE. Huttner A, et al. J Antimicrob Chemother. 2019 Jun 1;74(6):1656-1661. doi: 10.1093/jac/dkz095. J Antimicrob Chemother. 2019. PMID: 30859184 Clinical Trial.
BACKGROUND: Use of nitrofurantoin has increased significantly since its recent repositioning as a first-line agent for uncomplicated cystitis by multiple guidelines. ...OBJECTIVES: To reassess the plasma and urinary pharmacokinetic profile of macrocrystalline nitrofuran
BACKGROUND: Use of nitrofurantoin has increased significantly since its recent repositioning as a first-line agent for uncomplicated …
Antibiotic Prophylaxis During Catheter-Managed Postoperative Urinary Retention After Pelvic Reconstructive Surgery: A Randomized Controlled Trial.
Lavelle ES, Alam P, Meister M, Florian-Rodriguez M, Elmer-Lyon C, Kowalski J, Carter-Brooks C, Mazloomdoost D, Zyczynski H, Lowder J, Gutman R, Sutkin G. Lavelle ES, et al. Obstet Gynecol. 2019 Oct;134(4):727-735. doi: 10.1097/AOG.0000000000003462. Obstet Gynecol. 2019. PMID: 31503155 Clinical Trial.
Secondary outcomes were adverse symptoms possibly attributable to nitrofurantoin and bacterial resistance to nitrofurantoin. A sample size of 154 would detect a decrease in urinary tract infection incidence from 33% to 13%, with 80% power, two-sided alpha of 0.05, a …
Secondary outcomes were adverse symptoms possibly attributable to nitrofurantoin and bacterial resistance to nitrofurantoin. A …
190 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page